E
EvolutionaryScale
Health · New York City, United States · Founded 2023
“frontier model” for biology that can create proteins for use in drug discovery and materials science MoreLess
Evolutionary Scale operates at the intersection of artificial intelligence and biotechnology, providing advanced AI models that enable scientists to understand, imagine, and create proteins. The company leverages a trillion teraflops of computing power and vast datasets, including 2.78 billion natural proteins and 771 billion unique tokens of training data, to develop its ESM3 family of models. These models, available in small, medium, and large sizes, are designed to reason over the fundamental properties of protein sequences, structures, and functions. Evolutionary Scale serves clients in the scientific and research communities, offering tools that facilitate groundbreaking discoveries in protein engineering and synthetic biology. The business model revolves around providing access to these models through APIs and platforms, with an open-source version available under a non-commercial license. Revenue is generated through subscriptions and licensing fees for commercial use of their advanced models. The company adheres to a responsible development framework, ensuring ethical and safe deployment of its technologies.
Keywords: AI models, protein engineering, biotechnology, synthetic biology, ESM3, scientific research, computing power, APIs, responsible development, licensing fees.
Company overview
EvolutionaryScale company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2023
- Headquarters
- New York City, United States
- Employees
- 20
- Open positions
- 1
- Dealroom signal
- 62.9
Valuation & funding
EvolutionaryScale funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEEDOther financing | Jun 2024 | $142M | $568M | NVentures · Amazon · Lux Capital · Nat Friedman | ↗ |
Growth signals
EvolutionaryScale website traffic
Latest recorded traffic for EvolutionaryScale is 13K monthly website visits, down 27.8% over the last three months. EvolutionaryScale's team declined 35.5% over the past year.
Comparisons
EvolutionaryScale compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
EvolutionaryScale's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where EvolutionaryScale has talent and traffic
team presence
In the news
Latest news about EvolutionaryScale
Recent press, funding announcements, and product moves mentioning EvolutionaryScale — open to read from the original sources.
Market sentiment
What the market is saying about EvolutionaryScale
An AI-synthesized read of the highest-engagement posts about EvolutionaryScale on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EvolutionaryScale’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










